You are here:

International Union Against Tuberculosis and Lung Disease

Published on

Updated:

A HEALTHIER WORLD FOR ALL

The International Union Against Tuberculosis and Lung Disease strives to end suffering due to tuberculosis and lung diseases

Submissions for #UnionConf2024

Our submission platform has been buzzing with activity lately, here are a few updates from the #UnionConf2024:

Meanwhile, please spread the word among your networks to register for #UnionConf2024. We have early, affordable rates until 30 June. Details here: https://conf2024.theunion.org/registration/

This year we are also offering options for accommodation, airport transfers, etc. For more information, visit https://www.wclh2024bali.com/

IJTLD OPEN has launched

Category: News

The Union has launched the first issue of IJTLD OPEN – a fully-compliant, open access journal to enhance our coverage of tuberculosis (TB) and lung disease.

This first issue of IJTLD OPEN features Editorials (highlighting TB in children and adolescents; and the need for action after the UN High-Level Meeting on TB) and a mix of Original Articles on TPT initiation; screening of household contacts for TB infection; Omicron SARS-COV-2 infection’; timeliness metrics for screening and preventing TB; and priorities for EMR countries to achieve TB elimination.

Watch a video on the launch of IJTLD OPEN https://youtu.be/nXW7wHSG1DM

Nutritional acquired immunodeficiency (N-AIDS) a key driver of TB Pandemic

Category: News

One in five incident TB cases were attributable to malnutrition, more than double the number attributed to HIV/AIDS. Like HIV/AIDS, malnutrition is a cause of secondary immunodeficiency, known as nutritionally acquired immunodeficiency syndrome (N-AIDS). The Union and research partners have reviewed decades of data and made the case that N-AIDS deserves special consideration in the effort to eliminate TB.

The Impact of our work

The Union is the world’s first global health organisation, founded in 1920. We are a global leader in ending TB, we fight the tobacco industry, and we solve key problems in treating major diseases.